Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


EU approves Ngenla in growth hormone deficient children – Pfizer + OPKO Health

Written by | 9 Mar 2022

Pfizer and OPKO Health announced that the European Commission has granted marketing authorization for the next-generation long-acting recombinant human growth hormone Ngenla (somatrogon), a once-weekly injection to treat… read more.

CHMP recommends once-weekly Sogroya to treat growth hormone deficiency – Novo Nordisk

Written by | 8 Feb 2021

Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.